Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Mol Carcinog. 2011 Nov 28;52(2):155–166. doi: 10.1002/mc.21841

Table 4.

Interaction between cigarette smoking, estrogen status, and NSAID use with JAK, STAT, TYK and cancer risk


Gene SNP (Model)1 Variant2 Wildtype Interaction P Value p_ACT
OR (95% CI) OR (95% CI) OR (95% CI)
Colon Cancer No Recent Aspirin/NSAID Use Recent Aspirin/NSAID Use

TYK2  rs280521 (D) 1.00 (0.82, 1.21) 0.49 (0.38, 0.64) 0.72 (0.61, 0.84) 0.0266 0.1146

No Recent Estrogen Estrogen Use

STAT1  rs10199181 (R) 1.19 (0.85, 1.67) 0.37 (0.23, 0.62) 0.65 (0.50, 0.85) 0.0171 0.1406
 rs10208033 (A) 1.35 (0.93, 1.96) 0.39 (0.23, 0.65) 0.66 (0.44, 0.98) 0.0405 0.2628
 rs2280233 (A) 0.78 (0.54, 1.11) 0.58 (0.37, 0.90) 0.37 (0.25, 0.56) 0.0138 0.1239
 rs3771300 (A) 0.70 (0.49, 1.00) 0.58 (0.37, 0.89) 0.37 (0.24, 0.57) 0.0081 0.0805
 rs7562024 (A) 1.44 (0.97, 2.12) 0.48 (0.29, 0.78) 0.71 (0.48, 1.04) 0.0322 0.2250
STAT4  rs6572770 (A) 1.33 (0.83, 2.11) 0.40 (0.20, 0.79) 0.70 (0.51, 0.98) 0.0345 0.3578
TYK2  rs280519 (R) 1.50 (1.12, 2.01) 0.59 (0.39, 0.89) 0.66 (0.50, 0.87) 0.0403 0.1705

Non Smoker Recent Smoker

JAK2  rs10815160 (R) 1.17 (0.87, 1.58) 3.15 (1.60, 6.22) 1.11 (0.93, 1.32) 0.0166 0.0869
 rs1887429 (D) 0.79 (0.68, 0.92) 1.16 (0.90, 1.48) 0.94 (0.75, 1.19) 0.0131 0.0873
 rs7043371 (A) 1.21 (0.98, 1.49) 1.12 (0.80, 1.57) 1.67 (1.19, 2.34) 0.015 0.0895
STAT2  rs2229363 (D) 1.20 (0.74, 1.95) 0.39 (0.14, 1.07) 1.20 (1.01, 1.43) 0.0156 0.0302
STAT4  rs4853540 (A) 1.21 (0.86, 1.68) 0.79 (0.42, 1.48) 1.33 (1.07, 1.66) 0.0304 0.3310
STAT5A  rs7217728 (A) 1.15 (0.89, 1.49) 2.39 (1.44, 3.96) 0.98 (0.76, 1.26) 0.0098 0.0177
STAT5B  rs7218563 (A) 1.14 (0.88, 1.47) 2.30 (1.39, 3.83) 0.97 (0.76, 1.25) 0.0151 0.0398
STAT6  rs3024974 (D) 0.88 (0.72, 1.06) 1.48 (1.02, 2.15) 1.07 (0.89, 1.30) 0.0465 0.1709

Rectal Cancer No Recent Aspirin/NSAID Use Recent Aspirin/NSAID Use

JAK2  rs10815160 (A) 1.52 (0.92, 2.51) 0.49 (0.26, 0.91) 0.82 (0.63, 1.07) 0.019 0.1149
STAT6  rs324011 (D) 1.48 (1.14, 1.92) 0.86 (0.65, 1.14) 0.94 (0.68, 1.30) 0.0207 0.0782
TYK2  rs280521 (D) 1.40 (1.05, 1.85) 0.62 (0.44, 0.88) 0.82 (0.65, 1.03) 0.0092 0.0418

No Recent Estrogen Estrogen Use

JAK1  rs2256298 (A) 0.38 (0.14, 1.05) 0.94 (0.44, 2.02) 0.55 (0.35, 0.85) 0.0427 0.1931
 rs310198 (D) 0.69 (0.40, 1.19) 0.81 (0.49, 1.34) 0.54 (0.37, 0.79) 0.0276 0.1402
 rs310199 (A) 0.75 (0.34, 1.62) 1.01 (0.50, 2.06) 0.44 (0.27, 0.71) 0.0136 0.0837
 rs310211 (A) 0.32 (0.12, 0.80) 0.84 (0.42, 1.69) 0.51 (0.32, 0.82) 0.0138 0.0790

Non Smoker Recent Smoker

STAT2  rs2229363 (D) 1.74 (0.86, 3.54) 0.23 (0.03, 1.92) 1.36 (1.05, 1.76) 0.016 0.0309
1

Models: A - additive or co-dominant; D - dominant

2

Heterozygote/variant genotype if dominant model; variant if recessive or additive (or co-dominant); all comparisons are made to non-user/smoker and wildtype genotype